VieCure Clinical Advisory Council

Clinical Advisory Council

Cancer care is complex and ever-changing, particularly with recent advances in tumor biology and the development and approval of novel treatments guided by molecular testing. Due to this complexity, a conglomerate of the brightest minds is needed to understand and steer the future of the industry as there is far too much information for any one individual to master. VieCure’s Clinical Advisory Council comprises global leaders from top cancer programs, universities, and institutes who review clinical evidence, evaluate literature, and research Oncology treatments to develop algorithms and codified clinical rules to be actioned within
the VieCure™ A.I. platform.

VieCure Tumor Board

Why does VieCure need a
Clinical Advisory Council? 

  • Assist in creating and updating evidence-based treatment plans, rules, and algorithms for the VieCure clinical inference engine to facilitate cutting-edge point-of-care decision making

  • Analyze de-identified clinical data to expose opportunities such as potential new targets for research and treatment

  • Leverage professional network to improve patient care by providing strategic advice on new directions in cancer care and research across the globe

How will patient's benefit from VieCure's Clinical Advisory Council?

  • Oncologists have access to personalized patient treatment plans based on the most recent
    advances in cancer 

  • Tools within the VieCure platform are used to manage toxicities, monitor treatment compliance, achieve better outcomes and improve quality of life throughout treatment

  • Facilitate ongoing education by providing clinical providers easy access to the most current information regarding the patient’s disease, treatment, and supportive care

Clinical Advisory Council Members

FRED pic 1.png
VieCure Clinical Advisory Council Paul Bunn
VieCure Clinical Advisory Council Jennifer Choi

Fred Ashbury, PhD, MACE

Chief Scientific Officer - VieCure

Paul Bunn, MD, FASCO

Distinguished Professor, James Dudley Chair, University of Colorado, Colorado, USA

Jennifer Choi, MD

Chief, Division of Oncodermatology, Robert H. Lurie Comprehensive Cancer Center

Associate Professor, Dermatology, Feinberg School of Medicine, Northwestern University, Illinois, USA

VieCure Clinical Advisory Council  Lisa Madlensky
VieCure Clinical Advisory Council William Oh
VieCure Clinical Advisory Council Ian Olver

Lisa Madlensky, PhD, CGC

Professor, Molecular Genetics – University of California San Diego, California, USA

William Oh, MD

Chair, the Division of Hematology and Medical Oncology at the Mount Sinai Health System, New York, USA

Ian Olver, MD, PhD, AM

QA Professor (Adjunct), Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia

VieCure Clinical Advisory Council Jai Patel
VieCure Clinical Advisory Council Azra Raza

Jai Patel, PharmD,

Chair, Cancer Pharmacology and Pharmocogenomics

Levine Cancer Institute


Atrium Health, Charlotte, North Carolina, USA

Azra Raza, MD

Director, Myelodysplastic Syndrome Center, Department of Medicine, Division of Hematology/Oncology

Professor, Medicine, Columbia University, New York, USA

Keith Thompson, MD, FASCO

Chief Medical Officer, Montgomery Cancer Center, Alabama, USA

Location: Denver, CO or Remote

VieCure Clinical Advisory Council  Max Coppes
VieCure Clinical Advisory Council Pradip De
VieCure Clinical Advisory Council Shashikant Kulkami

Max J. Coppes, MD,

Nell J. Redfield Chair of Pediatrics at the University of Nevada Reno School of Medicine, Nevada, USA

Pradip De, PhD

Signal Transduction Pathway Consultant – Viecure

Assistant Professor, Department of Internal Medicine at the University of South Dakota, South Dakota, USA

Sashikant Kulkarni, MS, PhD, FACMG

Professor, Molecular and Human Genetics, Baylor College of Medicine, Texas, USA

Howard McLeod.jpeg
VieCure Clinical Advisory Council Casey Williams
Javier Torres-Roca.jpg

Howard McLeod, PharmD, BCOP

Medical Director for Precision Medicine, The Geriatric Oncology Consortium

 Fellow, American Society of Clinical Oncology

Casey Williams, PharmD, BCOP

Vice President of Research, Avera Cancer Institute, South Dakota, USA

Associate Professor, Internal Medicine, University of South Dakota, South Dakota, USA

Javier Torres-Roca, MD

Senior Member; Department of Radiation Oncology, Moffitt Cancer Center


Professor of Oncologic Sciences; University of South Florida College of Medicine